PROFUND ADVISORS LLC

Position in ARDX — Ardelyx, Inc.

CIK 1129919 BETHESDA, MD

Position in ARDX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,090,545

+$243,254 QoQ

Shares Held

182,061

+25.3% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. ARDX ranks #67 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,090,545	182,061	+25.3%	Shares	Sole	2026-04-27
2025-12-31	$847,291	145,333	+109.8%	Shares	Sole	2026-02-06
2025-09-30	$381,633	69,262	-8.7%	Shares	Sole	2025-11-06
2025-06-30	$297,335	75,851	-7.8%	Shares	Sole	2025-08-07
2025-03-31	$403,822	82,245	-20.5%	Shares	Sole	2025-05-08
2024-12-31	$524,420	103,436	-11.8%	Shares	Sole	2025-02-14
2024-09-30	$808,203	117,301	-1.2%	Shares	Sole	2024-11-14
2024-06-30	$879,959	118,753	-28.0%	Shares	Sole	2024-08-13
2024-03-31	$1,203,463	164,858	-26.0%	Shares	Sole	2024-05-08
2023-12-31	$1,380,417	222,648	+20.5%	Shares	Sole	2024-02-14
2023-09-30	$753,833	184,763	-50.7%	Shares	Sole	2023-11-13
2023-06-30	$1,270,677	374,831	+33.2%	Shares	Sole	2023-08-10
2023-03-31	$1,347,958	281,411	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.